☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Type2 Diabetes
AstraZeneca's Bydureon BCise (exenatide extended-release) Receives the US FDA's Approval for the Treatment of Type2 Diabetes
July 23, 2021
Sanofi Reports Results of Zynquista (sotagliflozin) in P-III InSynchrony Program for Type2 Diabetes and Terminates Its Collaborati...
July 29, 2019
Load more...
Back to Home